| Andrew David Egger, MD | |
|
2215 Fuller Rd, Ann Arbor, MI 48105-2303 | |
| (734) 769-7100 | |
| (734) 845-5995 |
| Full Name | Andrew David Egger |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 19 Years |
| Location | 2215 Fuller Rd, Ann Arbor, Michigan |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720201684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 4301088564 (Michigan) | Primary |
| Entity Name | Egger Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134739030 PECOS PAC ID: 8123445566 Enrollment ID: O20200831000629 |
News Archive
Chase Beisel heads the "Synthetic Biology of RNA" research group at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a branch of the Helmholtz Centre for Infection Research in Braunschweig and run in collaboration with the Julius-Maximilians-Universität in Würzburg.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
Teva Pharmaceutical Industries Ltd. and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
Scientists at The Scripps Research Institute have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.
A new study by UCSF cardiologists and researchers found that high concentrations of cocoa flavanols decrease blood pressure, improve the health of blood vessels and increase the number of circulating blood-vessel-forming cells in patients with heart disease. The findings indicate that foods rich in flavanols - such as cocoa products, tea, wine, and various fruits and vegetables - have a cardio-protective benefit for heart disease patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew David Egger, MD 2215 Fuller Rd, Ann Arbor, MI 48105-2303 Ph: (734) 769-7100 | Andrew David Egger, MD 2215 Fuller Rd, Ann Arbor, MI 48105-2303 Ph: (734) 769-7100 |
News Archive
Chase Beisel heads the "Synthetic Biology of RNA" research group at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a branch of the Helmholtz Centre for Infection Research in Braunschweig and run in collaboration with the Julius-Maximilians-Universität in Würzburg.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
Teva Pharmaceutical Industries Ltd. and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
Scientists at The Scripps Research Institute have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.
A new study by UCSF cardiologists and researchers found that high concentrations of cocoa flavanols decrease blood pressure, improve the health of blood vessels and increase the number of circulating blood-vessel-forming cells in patients with heart disease. The findings indicate that foods rich in flavanols - such as cocoa products, tea, wine, and various fruits and vegetables - have a cardio-protective benefit for heart disease patients.
› Verified 6 days ago
Michael Chia-shao Hsu, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Brian M Kelly, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2850 S Industrial Hwy Ste 400, Ann Arbor, MI 48104 Phone: 734-973-2400 | |
Edward A Hurvitz, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth Blvd, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Reina Nakamura, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Lisa A Diponio, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Alecia Kupser Daunter, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Ky Viet Dong Quach, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-936-7175 |